Stay updated with breaking news from Envision Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Using novel technology, a new test aims to sharpen predictions about the aggressiveness of individual prostate cancers.
UniSA researchers have identified three new biomarkers for prostate cancer to help identify and differentiate potentially aggressive cases of the disease which kills more than 300,000 men each year.
Versameb Announces Management Update - Dr Klaas Zuideveld appointed as Chief Executive Officer to accelerate the development of Versameb's lead pipeline products - Co-founder Prof Friedrich Metzger assumes role of Chief Scientific Officer to focus on leveraging the unique VERSagile RNA platform in the drive to realize its broad potential News provided by Share this article Share this article BASEL, Switzerland, Jan. 8, 2021 /PRNewswire/ -- Versameb AG ("Versameb"), a pre-clinical stage company focused on discovering and developing innovative RNA-based drugs, announces the appointment of Dr Kl...